Literature DB >> 6995325

Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.

E Yarkoni, H J Rapp.   

Abstract

The influence of mineral ol, squalane, squalene, hexadecane, or peanut oil and of the concentration of Tween 80 on the immunotherapeutic capability of emulsified Mycobacterium bovis Bacillus Calmette-Guérin (BCG) cell walls was studied in guinea pigs, each with an established dermal transplant of a syngeneic hepatocarcinoma and tumor cells in the draining lymph node. Immunotherapy consisted of an intratumoral injection of emulsified cell walls. Conditions were established under which therapeutically effective emulsions could be made with mineral oil, squalane, squalene, or hexadecane. Emulsions made with peanut oil failed to cause tumor regression. Emulsions of squalene or hexadecane were effective substitutes for mineral oil as carriers of cell walls in the absence of added Tween or at a Tween concentration one-hundredth of that used to stabilize the mineral oil-containing emulsions. Cell wall emulsions made with squalane were therapeutically effective over the same range of Tween concentrations used to prepare emulsions containing mineral oil. Cell wall emulsions made without added Tween demonstrated effective antitumor activity even after autoclaving. Emulsions made with Tween separated after autoclaving. Emulsions of whole killed BCG were immunotherapeutically as active as those made with cell walls.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995325      PMCID: PMC551033          DOI: 10.1128/iai.28.3.881-886.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  MAMMALIAN METABOLISM OF STRAIGHT-CHAIN SATURATED HYDROCARBONS.

Authors:  R D MCCARTHY
Journal:  Biochim Biophys Acta       Date:  1964-02-24

Review 2.  A guinea pig model for tumor immunology. A summary.

Authors:  H J Rapp
Journal:  Isr J Med Sci       Date:  1973-03

3.  Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine.

Authors:  S J Kleinschuster; H J Rapp; D C Lueker; R A Kainer
Journal:  J Natl Cancer Inst       Date:  1977-06       Impact factor: 13.506

4.  The effects of repeated injections of certain adjuvants on chemical carcinogenesis.

Authors:  E Bingham; K L Stemmer; H L Falk
Journal:  Ann Allergy       Date:  1967-12

5.  Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.

Authors:  E Yarkoni; M S Meltzer; H J Rapp
Journal:  Int J Cancer       Date:  1977-06-15       Impact factor: 7.396

6.  Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.

Authors:  E Yarkoni; H J Rapp
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

7.  Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.

Authors:  E Yarkoni; H J Rapp
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

8.  Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally administered killed BCG cells and BCG cell walls.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

9.  Immunotherapy of cancer with nonliving mycobacteria and cord factor (trehalose-6,6'-dimycolate) in aqueous medium.

Authors:  A Bekierkunst
Journal:  J Natl Cancer Inst       Date:  1976-10       Impact factor: 13.506

10.  Plasma cell neoplasia in a single host: a mosaic of different protein-producing cell types.

Authors:  M POTTER
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

2.  Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

Authors:  Christopher B Fox; Susan L Baldwin; Malcolm S Duthie; Steven G Reed; Thomas S Vedvick
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

3.  Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses.

Authors:  Signe Tandrup Schmidt; Malene Aaby Neustrup; Stine Harloff-Helleberg; Karen Smith Korsholm; Thomas Rades; Peter Andersen; Dennis Christensen; Camilla Foged
Journal:  Pharm Res       Date:  2017-05-17       Impact factor: 4.200

4.  Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.

Authors:  M Tsujimoto; S Kotani; F Kinoshita; S Kanoh; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

5.  A specific vaccine effective against stage I and stage II malignant disease in guinea pigs. Effect of variations in preparations and storage.

Authors:  E Yarkoni; J T Hunter; S Sukumar
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

6.  Regression by active specific immunotherapy of established dermal tumor transplants and lymph node metastases in guinea pigs.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

7.  Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.

Authors:  E Yarkoni; E Lederer; H J Rapp
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

8.  Immunotherapy of experimental cancer by intralesional injection of emulsified nonliving mycobacteria: comparison of Mycobacterium bovis (BCG), Mycobacterium phlei, and Mycobacterium smegmatis.

Authors:  E Yarkoni; H J Rapp
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

Review 9.  Squalene emulsions for parenteral vaccine and drug delivery.

Authors:  Christopher B Fox
Journal:  Molecules       Date:  2009-09-01       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.